Nanbiosis Committees

COORDINATION COMMITTEE

• Jaume Veciana, Scientific Director of NANBIOSIS; Director of  Molecular Nanosciences and Organic Materials Dpt. (ICMAB-CSIC)  and Coordinator of Platform Programme of CIBER BBN.
• Francisco Miguel Sánchez Margallo; Assistant Director of NANBIOSIS and Scientific Director of JUMISC
• Ramón Martínez Máñez, PI of  the Group of Applied Molecular Chemistry Center of Molecular Recognition and Technological Development of the Polytechnic University of Valencia (UPV-ADM-IQMA) Scientific Director of CIBER-BBN
• Raquel Ruiz Hidalgo; R&D&i Coordinator of JUMISC. Deputy Coordinator of NANBIOSIS
• Nerea Argárate; Responsible for Infrastructures and Research Services of CIBER BBN. Coordinator of NANBIOSIS
• José Becerra Ratia, Scientific Director of BIONAND, PI of the Group Bioengineering and Tissue Regeneration Laboratory of the University of Malaga-BIONAND, Deputy Scientific Director of CIBER-BBN

ACCESS  COMMITTEE

• Jaume Veciana, Scientific Director of NANBIOSIS; Director of  Molecular Nanosciences and Organic Materials Dpt. (ICMAB-CSIC)
• Francisco Miguel Sánchez Margallo; Assistant Director of NANBIOSIS and Scientific Director of JUMISC
• Niilo Saranummi (VTT Technical Research Centre of Finland).
• Patrick Boisseau (ETPN Chair Executive Board, CEA-Leti, Grenoble, France)
• Miguel Angel de Gregorio (Prof. of Interventional Radiology, University of Zaragoza)
• Virginio García Martínez (University of Extremadura, Spain)
• Hector Ferral (Department of Radiology, Section of Interventional Radiology, NorthShore University HealthSystem)
• Mª Eugenia Fernández Santos, (Director of Cellular Production Unit and Regenerative Medicine, Director of GMP facilities of Hospital Gregorio Marañón)

Scientific-Technical Advisory Committee

• Leif Sörnmo, Lund Institute of TechnologyLund University, Sweden
• Setefano Geuna, Associate Professor of Human Anatomy at the Department of Clinical and Biological Sciences of the University of Torino
• Jürguen Borlak, Director of Institute for Pharmaco- and Toxicogenomics, Hannover Medical School
• Joaquin Arribas, Director del Programa de Investigación Preclínica del Vall d’Hebron Instituto de Oncología (VHIO) and of CIBER of Oncology (CIBERONC)
• Anton Ussi, Operations and Finance director at EATRIS ERIC, the European Infrastructure for Translational Medicine
• Joan Bigorra, Innovation Director of the Hospital Clinic of Barcelona.
• Enrique Gómez Barrena, Medical Specialist of Trauma and Orthopaedics Area at the University Hospital La Paz
• Antonio Bernad,, Research Proffessor at Immunology and Onocology Department, National Center for Biotechnology (CNB)
• Manuel Sarasa, Professor of Comparative Anatomy and Pathological Anatomy at the University of Zaragoza, Scientific Director of Araclon Biotech S.L.
• Begoña Castro, Scientific Director of Histocell
• Pilar Calvo, Pharmaceutical Development Manager of PHARMAMAR
• Ignacio Santiago Álvarez, Professor of the University of Extremadura / Scientific Director IERA-GC, Badajoz
• Francisco Fernández Avilés, Chair of the Department of Cardiology, University Hospital Gregorio Marañón, Madrid